MediLOT es un ecosistema de EHR basado en una doble cadena de bloques con una arquitectura en capas única que incorpora capacidades de análisis de datos y aprendizaje automático sobre sus capas de control y datos, lo que permite que las API de aprendizaje automático con aplicaciones complejas se creen sobre el sistema. < / p>
Al tener un libro de contabilidad distribuido (Hyperledger ++) que registra todas las transacciones, los profesionales de la salud autorizados pueden recuperar los datos longitudinales completos del paciente en cualquier momento para uso clínico. Estos registros de salud son accesibles, con permiso de los pacientes, en diferentes instituciones. Por ejemplo, a un paciente que visita un hospital en el que nunca se le ha tratado anteriormente no se le pedirá que repita las investigaciones, ya que el médico o el clínico a quien se le han otorgado los derechos de acceso pueden acceder a su registro de salud completo a través de MediLOT. Además, las elecciones de consentimiento diferencial, como las relacionadas con la donación de órganos, las directivas médicas avanzadas y la investigación, también se pueden registrar en la cadena de bloques y acceder a ellas de manera universal. Específicamente, las elecciones de consentimiento que involucran el uso de datos para la investigación se pueden capturar de manera granular, lo que permite a los investigadores discernir de inmediato si los pacientes dan su consentimiento para que sus datos se utilicen para la investigación, incluido el uso de su material biológico, así como si se debe la identificación está permitida si es necesario.
Q1 2019
Q2 2019
Q3 2019
Q1 2020
Q2 2020
Q4 2020
Q2 2021
Verificado 0%
Atención. Existe el riesgo de que los miembros no verificados no sean realmente miembros del equipo
Verificado 0%
Atención. Existe el riesgo de que los miembros no verificados no sean realmente miembros del equipo
We believe that MediLOT is one of the exciting upcoming IEO and here are the reasons why:
First of all, the project is formulated and executed by a Singapore-based team with solid experience in medicine, tech and business development. The core members are from the blockchain and healthcare spheres:
- Co-founder Professor Beng Chin Ooi is 1 of the 2 Distinguished Professors and has spent over 30 years at the National University of Singapore's Department of Computer Science
- Co-founder Professor Meihui Zhang is a Professor at the Beijing Institute of Technology and a winner of prestigious China's Young Scholar Thousand Talents Program in 2018
- Co-founder Dr Marcus Tan is an Opthalmologist (Eye Specialist) and a Clinical Lecturer at the National University of Singapore
- CEO Koon Swee Lim has 25 years of senior management experience in healthcare industry, biomedical technology commercialisation and investments
The research done by MediLOT's team of professors has been cited in many reputable publications.
Backed by equity investor SG Innovate, the Singapore Government Venture Capital Fund, MediLot has a monopoly in Singapore, having already partnered with National University Hospital (the largest medical research institution in Singapore). More contracts with other Singapore hospitals will be announced. The team has also secured a foothold in the fast-growing China healthcare market.
Secondly, we like the idea of the project because it has a real use-case with seamless adoption of blockchain in our daily life. In summary, MediLOT is a dual blockchain-based Electronic Health Records platform that allows individual patients to grant healthcare providers, research institutions and pharmaceuticals access to their encrypted medical data by indicating the storage location. This is a highly secure solution which adheres to GDPR and other stringent data privacy regulations. Patients will be incentivized and empowered to permit the usage of their data to facilitate research, such as the research to create new drugs and treatments for cancers.
Thirdly, the token metrics is reasonable while the tokenomics is deflationary. IEO hardcap is $1,500,000 (for 8.5% of total token supply) while the initial circulating supply is $2,168,366. LOT Tokens retained by the MediLOT Platform will be burnt.
Last but not least, Ricky Ng, the founder of Bitsdaq, is one of the advisors, so we will keep an eye on it. Probably it will be an IEO on Bitsdaq Exchange
Medilot has flown under the radar for many of us not focused on developments in Asia but the project has a number of strong points. These include the fact that Medilot is operating in a lucrative sector and has a very much needed use case and is attempting to disrupt an industry that has been using outdated methods for quite some time. On top of this, the project has already developed an MVP and various aspects of the code are available to be verified. Medilot also has a strong core team with partnerships/collaborations with the National University of Singapore, the National University Health System, Singapore, and Chinese hospitals such as the Shandong Province Hospital, the Zhejiang Chinese Medical University Affiliated Jiangnan Hospital, and the Shenzhen Kingcome Hospital.
They have also been backed by SGInnovate, Signum Capital, and two other renowned investors who wish to remain private. which shows they are developing something significant, however, due to the scope of the project Medilot could prove to be a slow burner. There is a long wait until the mainnet with a launch set for Singapore in Q4 2020, and the Asia launch is in Q3 2021. This will leave the LOT token open to pure speculation for quite a while and could even allow the market to grow cold on the project. In addition, in the long term LOT tokens rely on adoption to maintain value and there’s no guarantee this will happen anytime soon. Furthermore, the team do state that in the preliminary stage, organisations who do not wish to stake LOT can deposit fiat which will be treated as a security deposit. This won’t help the token price when the project is getting off the ground, however, the team aim to retain 30% of all LOT Tokens via the platform’s fee structure regarding data sharing. Also LOT tokens held by the Platform will be held to insure against Black Swan events, and may also be burnt by the management as well as locked up by institutions and organisations that choose to stake tokens. The low token sale ratio also increases the importance of the team’s token management; however, with the team getting ready to conduct an IEO, there should be enough positive price action to attract anyone looking for short term returns. Anyone looking to follow the project in the long term should keep an eye on developments and adoption community growth over the next year as the project nears its first mainnet launch.
Esta oferta se basa en información proporcionada únicamente por el oferente y otra información públicamente disponible. El evento de venta o intercambio de fichas no tiene relación alguna con ICOholder e ICOholder no participa en él (incluido cualquier soporte técnico o promoción). Las ventas de tokens enumeradas de personas con las que ICOholder no tiene relación se muestran solo para ayudar a los clientes a realizar un seguimiento de la actividad que tiene lugar dentro del sector token general. Esta información no pretende constituir un asesoramiento en el que debe confiar. Debe obtener asesoramiento profesional o especializado o llevar a cabo su propia diligencia debida antes de tomar, o abstenerse de, cualquier acción en función del contenido de nuestro sitio. Los términos y condiciones que ingresen los contribuyentes con respecto a la adquisición de Tokens se encuentran entre ellos y el emisor del Token y ICOholder no es el vendedor de dichos Tokens. ICOholder no tiene ninguna responsabilidad legal por las declaraciones realizadas por terceros con respecto a cualquier venta de Token y cualquier reclamo por incumplimiento de contrato también debe realizarse directamente contra la entidad emisora del Token que se detalla en este documento.
Si tiene alguna inquietud acerca de la naturaleza, propiedad o legalidad de esta venta de tokens o de las personas involucradas en ella, póngase en contacto con info@icoholder.com . con información detallada sobre sus inquietudes.